In 60% of melanoma cases, the primary cause is BRAF mutation, thus we analyzed the effect of NPC-402 on BRAF expression and observed that BRAF is significantly downregulated by 3-fold at higher concentrations (Figure 4J, Figure S2A). Here, BRAF is linked to melanoma.